{
    "name": "asparaginase Erwinia chrysanthemi recombinant",
    "comment": "Rx",
    "other_names": [
        "Rylaze",
        "asparaginase Erwinia chrysanthemi recombinant-rywn"
    ],
    "classes": [
        "Enzymes",
        "Oncology"
    ],
    "source": "https://reference.medscape.com/drug/rylaze-asparaginase-erwinia-chrysanthemi-recombinant-4000167",
    "pregnancy": {
        "common": [
            "Based on findings from animal reproduction studies, can cause fetal harm when administered to pregnant females",
            "Advise pregnant females of potential fetal risk",
            "Pregnancy testing recommended in females of reproductive potential before initiating"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In embryofetal development studies, asparaginase ",
                    " was administered IM every other day during organogenesis to pregnant rats (at 3, 6, or 12 mg/m",
                    ") and rabbits (at 0.12, 0.30, or 0.48 mg/m",
                    ")",
                    "In rats given 12 mg/m",
                    " (~0.48 times the maximum recommended human dose [MRHD]), maternal toxicity of decreased body weight gain was observed, as was a fetal finding of increased incidence of partially undescended thymic tissue",
                    "In rabbits, maternal toxicity consisting of decreased body weight was observed at 0.48 mg/m",
                    " (~0.02 times the MRHD), increased postimplantation loss, decreased number of live fetuses, and gross abnormalities (eg, absent kidney, absent accessory lung lobe, additional subclavian artery, and delayed ossification) observed at doses â‰¥0.12 mg/m",
                    " (~0.005 times the MRHD)"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "Females of reproductive potential: Use effective nonhormonal contraceptive methods during treatment and for 3 months after last dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are unavailable regarding presence in human milk, effects on breastfed children, or effects on milk production ",
            "Advise women not to breastfeed during treatment and for 1 week after last dose "
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "History of serious hypersensitivity reactions to ",
                "E asparaginase",
                ", including anaphylaxis",
                "Serious pancreatitis during previous asparaginase therapy",
                "Serious thrombosis during previous asparaginase therapy",
                "Serious hemorrhagic events during previous asparaginase therapy"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Pancreatitis, including elevated amylase or lipase, reported; monitor for signs and symptoms; withhold or discontinue depending on severity",
                "Serious thrombotic events reported, including sagittal sinus thrombosis and pulmonary embolism; discontinue if thrombotic event occurs and administer antithrombotic therapy; consider resumption only if event was an uncomplicated thrombosis",
                "Bleeding reported; monitor for bruising, nose bleeds, hematuria, rectal bleeding, and gingival bleeding; monitor PT, PTT, and hypofibrinogenemia ",
                "Hepatotoxicity reported; evaluate bilirubin and transaminases before initiating and q2-3 weeks as clinically indicated during treatment "
            ],
            "specific": [
                {
                    "type": "Hypersensitivity",
                    "description": [
                        "Hypersensitivity reactions observed with L-asparaginase class products include angioedema, urticaria, lip swelling, eye swelling, rash or erythema, blood pressure decreased, bronchospasm, dyspnea, and pruritus",
                        "Premedicate patients prior to administration of therapy as recommended",
                        "Owing to risk for serious allergic reactions (eg, life-threatening anaphylaxis), administer in a setting with resuscitation equipment and other agents necessary to treat anaphylaxis "
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Abnormal liver test",
            "percent": "70"
        },
        {
            "name": "Nausea",
            "percent": "46"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "39"
        },
        {
            "name": "Fatigue",
            "percent": "36"
        },
        {
            "name": "Infection",
            "percent": "30"
        },
        {
            "name": "Headache",
            "percent": "30"
        },
        {
            "name": "Pyrexia",
            "percent": "27"
        },
        {
            "name": "Hypersensitivity",
            "percent": "24"
        },
        {
            "name": "Febrile neutropenia",
            "percent": "24"
        },
        {
            "name": "Decreased appetite",
            "percent": "21"
        },
        {
            "name": "Stomatitis",
            "percent": "21"
        },
        {
            "name": "Bleeding",
            "percent": "21"
        },
        {
            "name": "Hyperglycemia",
            "percent": "21"
        },
        {
            "name": "Abdominal pain",
            "percent": "18"
        },
        {
            "name": "Tachycardia",
            "percent": "18"
        },
        {
            "name": "Diarrhea",
            "percent": "18"
        },
        {
            "name": "Constipation",
            "percent": "15"
        },
        {
            "name": "Dehydration",
            "percent": "15"
        },
        {
            "name": "Neuropathy peripheral",
            "percent": "15"
        },
        {
            "name": "Cough",
            "percent": "15"
        },
        {
            "name": "Insomnia",
            "percent": "15"
        },
        {
            "name": "Febrile neutropenia",
            "percent": "24"
        },
        {
            "name": "Abnormal liver test",
            "percent": "12"
        },
        {
            "name": "Infection",
            "percent": "12"
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": "9"
        },
        {
            "name": "Abdominal discomfort",
            "percent": "9"
        },
        {
            "name": "abdominal distension",
            "percent": "9"
        },
        {
            "name": "pancreatitis",
            "percent": "6"
        },
        {
            "name": "General disorders and administration site conditions",
            "percent": "6"
        },
        {
            "name": "Infusion site reaction",
            "percent": "6"
        },
        {
            "name": "pain",
            "percent": "6"
        },
        {
            "name": "Infections and infestations",
            "percent": "6"
        },
        {
            "name": "Viral infection",
            "percent": "3"
        },
        {
            "name": "bacterial infection",
            "percent": "3"
        },
        {
            "name": "fungal infection",
            "percent": null
        },
        {
            "name": "Investigations",
            "percent": null
        },
        {
            "name": "Blood fibrinogen decreased",
            "percent": null
        },
        {
            "name": "activated partial thromboplastin time prolonged",
            "percent": null
        },
        {
            "name": "Metabolism and nutrition disorders",
            "percent": null
        },
        {
            "name": "Acidosis",
            "percent": null
        },
        {
            "name": "Musculoskeletal and connective",
            "percent": null
        },
        {
            "name": "tissue disorders",
            "percent": null
        },
        {
            "name": "Bone pain",
            "percent": null
        },
        {
            "name": "muscular weakness",
            "percent": null
        },
        {
            "name": "muscle spasms",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Paresthesia",
            "percent": null
        },
        {
            "name": "Psychiatric disorders",
            "percent": null
        },
        {
            "name": "Agitation",
            "percent": null
        },
        {
            "name": "anxiety",
            "percent": null
        },
        {
            "name": "irritability",
            "percent": null
        },
        {
            "name": "Renal and urinary disorders",
            "percent": null
        },
        {
            "name": "Acute kidney injury",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous disorders",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Hypotension",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Stomatitis",
            "percent": null
        },
        {
            "name": "Dehydration",
            "percent": null
        },
        {
            "name": "Musculoskeletal pain",
            "percent": null
        },
        {
            "name": "Pyrexia",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "Decreased appetite",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Fatigue",
            "percent": null
        },
        {
            "name": "Hyperglycemia",
            "percent": null
        }
    ]
}